-
- A. Gregory Sorensen
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Shveta Patel
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Carla Harmath
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Sarah Bridges
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Jennifer Synnott
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Amy Sievers
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Young-Ho Yoon
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- E. John Lee
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Michael C. Yang
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Robert F. Lewis
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Gordon J. Harris
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Michael Lev
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Pamela W. Schaefer
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Bradley R. Buchbinder
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Glenn Barest
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Kei Yamada
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- John Ponzo
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- H. Young Kwon
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Joseph Gemmete
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Jeff Farkas
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Andrew L. Tievsky
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Richard B. Ziegler
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Megan R.C. Salhus
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
-
- Robert Weisskoff
- From the MGH NMR Center and Neuroradiology Division, Department of Radiology, Massachusetts General Hospital, Charlestown, MA.
この論文をさがす
説明
<jats:p> PURPOSE: Lesion volume is often used as an end point in clinical trials of oncology therapy. We sought to compare the common method of using orthogonal diameters to estimate lesion volume (the diameter method) with a computer-assisted planimetric technique (the perimeter method). </jats:p><jats:p> METHODS: Radiologists reviewed 825 magnetic resonance imaging studies from 219 patients with glioblastoma multiforme. Each study had lesion volume independently estimated via the diameter and perimeter methods. Cystic areas were subtracted out or excluded from the outlined lesion. Inter- and intrareader variability was measured by using multiple readings on 48 cases. Where serial studies were available in noncystic cases, a mock response analysis was used. </jats:p><jats:p> RESULTS: The perimeter method had a reduced interreader and intrareader variability compared with the diameter method (using SD of differences): intrareader, 1.76 mL v 7.38 mL (P < .001); interreader, 2.51 mL v 9.07 mL (P < .001) for perimeter and diameter results, respectively. Of the 121 noncystic cases, 23 had serial data. In six (26.1%) of those 23, a classification difference occurred when the perimeter method was used versus the diameter method. </jats:p><jats:p> CONCLUSION: Variability of measurements was reduced with the computer-assisted perimeter method compared with the diameter method, which suggests that changes in volume can be detected more accurately with the perimeter method. The differences between these techniques seem large enough to have an impact on grading the response to therapy. </jats:p>
収録刊行物
-
- Journal of Clinical Oncology
-
Journal of Clinical Oncology 19 (2), 551-557, 2001-01-15
American Society of Clinical Oncology (ASCO)